Bontril
Generic name: phendimetrazine [ fen-di-MEH-tra-zeen ]
Brand names: Bontril, Melfiat
Drug classes: Anorexiants, CNS stimulants
The Bontril Slow Release brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
See also: Bontril PDM
What is Bontril?
Bontril is similar to an amphetamine. Phendimetrazine stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite.
Bontril is used together with diet and exercise to treat obesity.
Bontril may also be used for purposes not listed in this medication guide.
Warnings
You should not use Bontril if you have glaucoma, overactive thyroid, severe heart problems, uncontrolled high blood pressure, advanced coronary artery disease, extreme agitation, or a history of drug abuse.
Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine. A dangerous drug interaction could occur, leading to serious side effects.
Weight loss during pregnancy can harm an unborn baby, even if you are overweight. Do not use Bontril if you are pregnant.
Do not stop using Bontril suddenly after long-term use, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using this medicine. Do not crush, chew, break, or open the extended-release capsule. Swallow the capsule whole. Breaking or opening the pill may cause too much of the drug to be released at one time.
Before taking this medicine
You should not use Bontril if you are allergic to phendimetrazine, or if you have:
-
severe heart problems;
-
advanced coronary artery disease (clogged arteries);
-
severe or uncontrolled high blood pressure;
-
overactive thyroid;
-
glaucoma;
-
extreme agitation or nervousness; or
-
a history of drug abuse.
Do not use Bontril if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
Weight loss during pregnancy can harm an unborn baby, even if you are overweight. Do not use phendimetrazine if you are pregnant. Tell your doctor right away if you become pregnant during treatment.
To make sure you can safely take Bontril, tell your doctor if you have ever had:
-
heart disease or coronary artery disease;
-
high blood pressure;
-
diabetes (your diabetes medication dose may need to be adjusted); or
-
an allergy to food dye or aspirin.
Bontril is not approved for use by anyone younger than 12 years old.
It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.
How should I take Bontril?
Take Bontril exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.
Bontril is usually taken 1 hour before meals. Follow your doctor's dosing instructions very carefully.
Never use phendimetrazine in larger amounts, or for longer than prescribed. Taking more of this medication will not make it more effective and can cause serious, life-threatening side effects.
Bontril is for short-term use only. The effects of appetite suppression may wear off after a few weeks.
Phendimetrazine may be habit-forming. Misuse can cause addiction, overdose, or death. Selling or giving away phendimetrazine is against the law.
Call your doctor at once if you think this medicine is not working as well, or if you have not lost at least 4 pounds within 4 weeks.
Do not stop using Bontril suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using this medicine.
Store at room temperature away from moisture and heat. Keep the bottle tightly closed when not in use.
Dosing information
Usual Adult Dose for Obesity:
Extended-release:
-105 mg orally once a day, 30 to 60 minutes before morning meal
Immediate-release:
-35 mg orally 2 or 3 times a day, one hour before meals
-Maximum dose: 70 mg orally 3 times a day, one hour before meals
Comments:
-For use as monotherapy only.
-Extended-release: The active drug in each extended release capsule approximates the action of three 35 mg immediate-release doses taken at 4 hour intervals.
-Immediate-release: Dosage should be individualized to obtain an adequate response with the lowest effective dose; 17.5 mg per dose may be adequate in some cases.
Use: Management of exogenous obesity as a short-term adjunct in a regimen of weight reduction based on caloric restriction in patients with
-an initial BMI of 30 kg/m2 or greater OR
-an initial BMI of 27 kg/m2 or greater in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia) who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
What happens if I miss a dose?
Use the medicine as soon as you can, but skip the missed dose if it is late in the day. Do not use two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of phendimetrazine can be fatal.
Overdose symptoms may include confusion, panic, hallucinations, extreme restlessness, nausea, vomiting, diarrhea, stomach cramps, feeling tired or depressed, irregular heartbeats, weak pulse, seizure, or slow breathing (breathing may stop).
What to avoid
Avoid driving or hazardous activity until you know how phendimetrazine will affect you. Your reactions could be impaired.
Drinking alcohol with this medicine can cause side effects.
Bontril side effects
Get emergency medical help if you have signs of an allergic reaction to Bontril: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
-
pounding heartbeats or fluttering in your chest;
-
tremors, severe agitation, feeling restless, trouble sleeping;
-
unusual changes in mood or behavior;
-
little or no urination; or
-
increased blood pressure - severe headache, blurred vision, pounding in your neck or ears, anxiety, nosebleed.
Common Bontril side effects may include:
-
flushing (warmth, redness, or tingly feeling);
-
increased sweating or urination;
-
dizziness, headache;
-
blurred vision;
-
dry mouth, nausea;
-
diarrhea, constipation, stomach pain; or
-
increased or decreased interest in sex.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Zepbound
Zepbound (tirzepatide) is used for weight loss to help adults lose and keep weight off, and sleep ...
Wegovy
Wegovy is used for weight loss for overweight or obese patients and to lower the risk of ...
Mounjaro
Mounjaro (tirzepatide) is used for type 2 diabetes to lower blood sugar levels and is helpful for ...
Saxenda
Saxenda (liraglutide) injection is used for weight loss in obese or overweight patients. Includes ...
What other drugs will affect Bontril?
Other drugs may interact with phendimetrazine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
More about Bontril Slow Release (phendimetrazine)
- Check interactions
- Compare alternatives
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anorexiants
Patient resources
Other brands
Bontril PDM, Melfiat, Obezine, Phendiet, ... +2 more
Professional resources
- Bontril prescribing information
- Bontril Slow-Release Capsules (FDA)
- Phendimetrazine (AHFS Monograph)
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Bontril only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2024 Cerner Multum, Inc. Version: 9.01.